Non-Invasive Biomarkers of NASH

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH).  Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

STUDIES ARE ENROLLING NOW!

DEPRESSION

If you or someone you know is affected by depression, upcoming clinical trials may be an option. Learn more today!

Healthy Volunteers

Help Build a Healthier Future! Explore upcoming research studies for healthy adults.